The quarterly Global Corporate Venturing webinar, sponsored by software provider Relevant Equity Systems, provided the opportunity to highlight some of the trends revealed by our database of deals and fundraising between April and June, as well providing an opportunity for corporate venturing executives to air their feelings about some negative comments by one of the venture industry’s best-known executives, Union Square Ventures’ Fred Wilson.
This second quarter (Q2) has an estimated 246 corporate venture capital (CVC) investments worth $5bn, with 40 exits and further flotations expected as registrations and roadshows particular in biotech and enterprise information technology (IT) are picking up by number. (Last year’s value of initial public offerings was boosted by Facebook’s $104bn flotation.)
There will be further coverage in the July issue of Global Corporate Venturing, including its 12-page data supplement, but a few takeaways: M&A from portfolio companies was up by a third; series A leads by number of deals; IT most active, healthcare rebounds; and Asia and Europe dealmaking is increasing but US still leads.